SLAB — Silicon Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $6.76bn
- $6.32bn
- $784.76m
- 82
- 15
- 91
- 68
Annual cashflow statement for Silicon Laboratories, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 91.4 | 2,117 | -34.5 | -191 | -64.9 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -10.4 | -2,298 | 65.2 | 61.5 | 80.3 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -47.6 | 20.7 | -100 | 37.5 | 41.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 71.8 | -100 | -30.3 | -13.9 | 95.7 |
| Capital Expenditures | -26.5 | -28.6 | -22.3 | -11.7 | -33.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 267 | 2,300 | 492 | 125 | 21.9 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 241 | 2,271 | 470 | 113 | -12 |
| Financing Cash Flow Items | -15.4 | -22.2 | -18.2 | -16.4 | -15.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -887 | -1,299 | -712 | -45.1 | -1.07 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -575 | 872 | -272 | 54.1 | 82.6 |